Trials / Completed
CompletedNCT06202612
A SHR0302 BA Study on Healthy Subjects
A Bioavailability Study of SHR0302 Tablet in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate and compare the pharmacokinetics of SHR0302 two different kind tablets in Healthy subjects after administration two kind tablets (quick release tablets and sustained-release tablets).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302 quick release tablets | SHR0302 quick release tablets 8 mg |
| DRUG | SHR0302 sustained-release tablets | SHR0302 sustained-release tablets 10 mg |
Timeline
- Start date
- 2024-01-16
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
- First posted
- 2024-01-11
- Last updated
- 2025-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06202612. Inclusion in this directory is not an endorsement.